ArticleFrontiers in oncology2024

Enhanced pro-apoptotic activity of rituximab through IBTK silencing in non-Hodgkin lymphoma B-cells.

Eleonora Vecchio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.